LM

Luigi Manenti

CMO

Alentis Therapeutics


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Alentis Therapeutics
Industry
pharmaceuticals
Employees
64.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
365600000.0
Latest Funding
Series D

Professional Summary

Luigi Manenti serves as CMO at Alentis Therapeutics. Alentis Therapeutics operates in the pharmaceuticals sector with approximately 64.0 employees. Alentis Therapeutics generates annual revenue of 1000000.0. To date, Alentis Therapeutics has raised 365600000.0 in total funding, with the most recent round being Series D.

Industry & Role Insights

  • • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
  • • Our database includes 201,465 c suite-level executives.

Technologies

Outlook Microsoft Office 365 Google Font API WordPress.org Mobile Friendly Basis Circle

Keywords

claudin1 cldn1 claudin oncology cancer kidney fibrosis rare diseases nephrology lung fibrosis liver fibrosis alef02 drug development drug discovery pulmonology hepatology fibrosis antibodydrug conjugates adc hnscc idiopathic pulmonary fibrosis ancaassociated vasculitis alep02 alep03 lixudebart pharmaceutical manufacturing claudin-1 monoclonal antibodies antibody-drug conjugates adcs solid tumors cancer therapy r&d pipeline clinical development tumor targeting immune checkpoint blockade first-in-class biotechnology fda fast track designation human clinical trials jacques lacan's constructs cancer immunotherapy therapeutic target exposed claudin-1 tumor microenvironment extracellular matrix remodeling pharmaceutical development oncology drug development fibrotic signaling renal diseases preclinical programs t-cell engagers anticancer antibody biologic drugs pharmaceutical pipelines personalized medicine cancer biomarkers tumor microenvironment studies biopharma clinical-stage biotech targeted therapies neoplastic diseases research & development fdaind clearance lean development biotherapeutics cancer care clinical trials industries pipeline phase 1/2 trials clinical candidate anti-claudin-1 therapies cancer treatment fibrosis reversal squamous cancers organ fibrosis clinical-stage biotechnology innovative biopharmaceuticals precision medicine unmet medical needs patient populations advanced liver fibrosis anca-associated vasculitis therapeutic potential biotechnology industry pharmaceutical industry fibrotic diseases proprietary technology platform first-in-class therapies clinical operations basel switzerland patient demographics healthcare providers clinical trial participants partnerships funding series d financing competitive landscape hospital & health care pharmaceuticals medical health care health wellness & fitness

Related Executives

YM
Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions
RB
Ronan Brown Chief Operating Officer at 4G Clinical
HK
Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation
LJ
Lars Jensen CEO at A-apoteket
TL
Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Luigi Manenti in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Alentis Therapeutics.

Luigi Manenti's Position in the MessageCEO Database

  • •Luigi Manenti is 1 of 1 verified executive contact we track at Alentis Therapeutics.
  • •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
  • •5 verified contacts work at pharmaceuticals companies in the 64.0 employee range (same size as Alentis Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

Frequently Asked Questions

How do I reach Luigi Manenti directly?

Luigi Manenti's verified email address is available to MessageCEO Pro subscribers. They currently serve as CMO at Alentis Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Luigi Manenti work for?

Luigi Manenti is CMO at Alentis Therapeutics, a company in the pharmaceuticals sector with 64.0 employees.

Can I pitch or sell to Luigi Manenti?

As CMO at Alentis Therapeutics, Luigi Manenti is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Luigi Manenti directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Luigi Manenti in?

Luigi Manenti works in the pharmaceuticals industry as CMO at Alentis Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Luigi Manenti's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Luigi Manenti's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: October 30, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans